Measles: not just another viral exanthem (Q35079388)

6 August 2017

1 reference

title

Measles: not just another viral exanthem (English)

1 reference

6 August 2017

1 reference

Trevor Duke

1

1 reference

PubMed ID

12620751

6 August 2017

Charles S Mgone

series ordinal

2

1 reference

PubMed ID

12620751

6 August 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

361

1 reference

6 August 2017

9359

1 reference

6 August 2017

763-773

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

6 August 2017

1 reference

7 January 2021

Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

SLAM (CDw150) is a cellular receptor for measles virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Genetic diversity of wild-type measles viruses: implications for global measles elimination programs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Thymic aplasia with lymphopenia, plasma cells, and normal immunoglobulins. Relation to measles virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Severe measles in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Long-term antibody response after measles vaccination in an isolated arctic society in Greenland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Measles Encephalomyelitis — Clinical and Immunologic Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Measles encephalomyelitis: Lack of evidence of viral invasion of the central nervous system and quantitative study of the nature of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Immunologic and virologic studies of measles inclusion body encephalitis in an immunosuppressed host: the relationship to subacute sclerosing panencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Molecular analysis of measles virus genome derived from SSPE and acute measles patients in Papua, New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

High incidence of subacute sclerosing panencephalitis in south India

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Changing epidemiological features of subacute sclerosing panencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Measles virus and immunomodulation: molecular bases and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Measles: immunosuppression, interleukin-12, and complement receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Infection of monocytes during measles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

In vitro studies of the role of monocytes in the immunosuppression associated with natural measles virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Measles virus-induced immunosuppression in vitro is associated with deregulation of G1 cell cycle control proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Pattern of exposure and measles mortality in Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Miliary Tuberculosis in Children: A Clinical Review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

The diagnosis of pulmonary tuberculosis in malnourished Kenyan children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Age-specific occurrence rates of measles in urban, peri-urban, and rural environments: implications for time of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Measles in rural Bangladesh: issues of validation and age distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Coinfection is common in measles-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

High measles mortality in infancy related to intensity of exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Prospective study of measles in hospitalized, human immunodeficiency virus (HIV)-infected and HIV-uninfected children in Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Measles infection in HIV-infected African infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Immune modulation after measles vaccination of 6-9 months old Bangladeshi infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium- or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kinshasa, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Reduced seroconversion to measles in infants given vitamin A with measles vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Effect of vitamin A supplementation on measles vaccination in nine-month-old infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Vitamin A administered with measles vaccine to nine-month-old infants does not reduce vaccine immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Measles and pertussis in developing countries with good vaccine coverage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Five cases of measles secondary vaccine failure with confirmed seroconversion after live measles vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

The role of secondary vaccine failures in measles outbreaks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

1 reference

7 January 2021

RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

MMR vaccination and autism 1998

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

A randomized, controlled trial of vitamin A in children with severe measles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

1 reference

7 January 2021

Meta-analysis of trials of prophylactic antibiotics for children with measles: inadequate evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Efficacy of a single oral dose of 200,000 IU of oil-soluble vitamin A in measles-associated morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Measles pneumonia in young adults. An analysis of 106 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Measles pneumonia: lung puncture findings in 56 cases related to chest X-ray changes and clinical features.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Bacterial pneumonia: commoner than perceived.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Crippling lung disease after measles and adenovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Factors predisposing to abnormal pulmonary function after adenovirus type 7 pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Measles case fatality by sex, vaccination status, and HIV-1 antibody in Zambian children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

The prophylaxis and treatment of bacterial complications of measles with benzethacil and aqueous procaine penicillin G

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Sulphanilamide in Measles.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Nosocomial bacteremias in measles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

The pneumonia of measles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Clinical predictors of hypoxaemia in Gambian children with acute lower respiratory tract infection: prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Hypoxaemia in acute respiratory and non-respiratory illnesses in neonates and children in a developing country

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Intravenous immunoglobulins as therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Successful treatment of disseminated measles in a patient with acquired immunodeficiency syndrome: consideration of antiviral and passive immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Epidemic measles in a highly immunized rural West African (Gambian) village

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Decline in measles case fatality ratio after the introduction of measles immunization in rural Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Non-specific effects of vaccines in developing countries. We need evidence about the effect of vaccines on mortality from all causes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

First 5 years of measles elimination in southern Africa: 1996-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

Implications of the human immunodeficiency virus epidemic for control and eradication of measles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912661-X

7 January 2021

10.1016/S0140-6736(03)12661-X

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12620751